Core Viewpoint - Beijing Ruimait Medical Technology Co., Ltd. is experiencing positive market movement, with a recent stock increase of 1.49% and a total market capitalization of 8.673 billion yuan, driven by its focus on respiratory health medical devices and favorable currency conditions [1][2]. Company Overview - The company specializes in manufacturing medical devices and consumables in the respiratory health sector, including various types of sleep apnea machines and monitoring devices [2][7]. - As of September 30, the company reported a revenue of 808 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 34.24%, and a net profit of 180 million yuan, up 43.87% [8]. Financial Performance - The overseas revenue contribution is significant, accounting for 64.21% of total revenue, benefiting from the depreciation of the yuan [3]. - The company has distributed a total of 228 million yuan in dividends since its A-share listing [8]. Shareholder and Market Activity - As of September 30, the number of shareholders increased by 16.36% to 7,971, while the average circulating shares per person decreased by 14.20% [8]. - The stock has seen a net inflow of 2.0224 million yuan from major investors, indicating a growing interest in the stock despite a lack of clear trends in major fund movements [4][5]. Technical Analysis - The average trading cost of the stock is 88.45 yuan, with current price action suggesting a trading range between resistance at 97.44 yuan and support at 95.40 yuan, indicating potential for short-term trading strategies [6].
瑞迈特涨1.49%，成交额2.46亿元，近5日主力净流入3128.80万